.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Cantor Fitzgerald
Chinese Patent Office
Boehringer Ingelheim
AstraZeneca
Accenture
Fish and Richardson
US Army
Healthtrust

Generated: February 21, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 04023130

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Bayer HlthcareNEXAVARsorafenib tosylateTABLET;ORAL021923-001Dec 20, 2005RXYesYes➤ Sign Up➤ Sign UpYYTREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA, ADVANCED RENAL CELL CARCINOMA, OR DIFFERENTIATED THYROID CARCINOMA.
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist